RSM, the 6th largest global network of consulting and auditing firms, carried out the financial due diligence for ProductLife Group (PLG), a regulatory consulting firm for the life sciences industry, during the acquisition of Strategiqual, a French consulting firm specializing in regulatory affairs, quality, clinical affairs, and market access for the pharmaceutical and medical device industries.

To support ProductLife Group, a leader in quality and regulatory affairs, the RSM team was supervised by Eric Fougedoire, RSM Partner.

The acquisition of Strategiqual marks the fourth external growth transaction entrusted to RSM’s Corporate Finance department. These transactions strengthen RSM's role as a trusted advisor to regulatory consulting firms in the life sciences industry during their strategic acquisitions.

ProductLife Group (PLG), a global leader in regulatory and scientific services, vigilance, and quality for the healthcare industries, announces the acquisition of Strategiqual, a French consulting firm providing expertise in regulatory affairs, quality, clinical affairs, and market access for pharmaceutical products and medical devices.

Founded in 2012, Strategiqual offers consulting and services in strategy, quality, regulatory affairs, vigilance, compliance, auditing, and training. With an in-depth knowledge of European regulations and specific national requirements in France, Strategiqual’s team supports pharmaceutical and medical device companies in ensuring product and process compliance. The company benefits from unique regulatory expertise, strengthened by close partnerships with institutional players, professional organizations, incubators, and universities.
 

Florent Audureau, President de Strategiqual : « Since our inception, we have provided quality and regulatory expertise to help our clients bring their products to market and maintain them there over time. By joining PLG, we strategically complement our respective solutions, now being able to cover the full lifecycle of healthcare products at the French, European, and international levels »

Xavier Duburcq, PDG de PLG : "This high-value acquisition is part of our rigorous mergers and acquisitions strategy, strengthening our position as a leading provider of pharmaceutical and medical device services while continuing to enhance the service offering provided by the PLG group. With this transaction, we respond to our clients’ search for best practices in quality assurance, due to the increasing complexity of development, vigilance, and manufacturing processes, and the associated regulatory requirements."

The RSM team 

The RSM team consisted of  :

• Financial due diligence : Eric Fougedoire, Charles Tiran, Maxime Pothron, Tony Dixon.